Real ChatGPT answer · index seedvnoBqt9rKiwcompleteHealth and wellness · women's healthinformational
What are the cardiovascular and thrombotic risk differentials between transdermal estradiol patches and oral estrogen formulations when initiating HRT at age fifty-two?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the cardiovascular and thrombotic risk differentials between transdermal estradiol patches and oral estrogen formulations when initiating HRT at age fifty-two?
3 real searches · 1 real-search pass
transdermal versus oral menopausal hormone therapy venous thromboembolism stroke cardiovascular risk guideline 2024 NAMS ACOG Endocrine SocietyGoogle ↗
OBSERVED
NICE menopause hormone therapy transdermal oral VTE stroke cardiovascular risk guidelineGoogle ↗
OBSERVED
menopausal hormone therapy timing hypothesis age under 60 within 10 years cardiovascular risk oral transdermal randomized trials reviewGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
transdermal versus oral menopausal hormone therapy venous thromboembolism stroke cardiovascular risk guideline 2024 NAMS ACOG Endocrine Society Google ↗
NICE menopause hormone therapy transdermal oral VTE stroke cardiovascular risk guideline Google ↗
menopausal hormone therapy timing hypothesis age under 60 within 10 years cardiovascular risk oral transdermal randomized trials review Google ↗
- Postmenopausal Estrogen Therapy Route of Administration and Risk of Venous Thromboembolism · acog.org
- Recommendations | Menopause: identification and management | Guidance · nice.org.uk
- European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause | European Journal of Endocrinology · doi.org
- European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause | European Journal of Endocrinology · academic.oup.com
- Rationale and impact | Menopause: identification and management | Guidance · nice.org.uk
- Hormones and Aging: An Endocrine Society Scientific Statement · pmc.ncbi.nlm.nih.gov
- The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review · pubmed.ncbi.nlm.nih.gov
- Comparative Evidence Between Transdermal and Oral Menopausal Hormone Therapy · ncbi.nlm.nih.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
transdermal versus oral menopausal hormone therapy venous thromboembolism stroke cardiovascular risk guideline 2024 NAMS ACOG Endocrine Society OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
NICE menopause hormone therapy transdermal oral VTE stroke cardiovascular risk guideline OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
menopausal hormone therapy timing hypothesis age under 60 within 10 years cardiovascular risk oral transdermal randomized trials review OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |